Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...
WORKING PAPERS
September 30, 2020
One-quarter of married, fertile-age women in Sub-Saharan Africa report not wanting a pregnancy and yet do not use contraceptives. To study this issue, we collect detailed data on women’s subjective probabilistic beliefs and estimate a structural model of contraceptive choices
CGD NOTES
May 05, 2020
Much of the policy debate regarding COVID-19 medical equipment focuses on the question of which form of patient respiratory support is effective in low-resources settings. However, irrespective of the specific form of respiratory support used, the long-term and cost-effective functioning of all form...
Blog Post
April 30, 2020
In the months before the current crisis, CGD’s global health policy team partnered with Pharos Global Health Advisors to understand competing fiscal and programmatic pressures across the health sector. It aimed to drill down on challenges, risks, and opportunities associated with transitions from di...
CGD NOTES
February 06, 2020
Over the past two decades, global health innovation has delivered important new tools for use in low- and middle-income countries (LMICs) and saved many lives. Nonetheless, the current innovation ecosystem suffers from significant limitations that are likely to worsen with aid transition.
Blog Post
January 23, 2020
As middle income countries transition from donor support and increasingly use domestic funds to finance health programmes that have previously received substantial external aid, it is imperative that they build and use Health Technology Assessment capacities so that they can prioritise inv...